Ayşe Simay Metin earned her BSc (2021) and MSc (2024) degrees from the Department of Molecular Biology and Genetics at Istanbul Kültür University. She is currently pursuing her PhD in the Department of Medical Biology and Genetics at Istinye University. She has served as a research fellow in various cancer biology projects and has contributed to several publications. Her research focuses on the effects of cell signaling pathways and microRNAs on fatty acid metabolism. In collaboration with her team, she co-developed a CRISPR-based gene therapy project for spinal muscular atrophy, which was awarded first prize in an international competition. Her research interests include tumor metabolism, metabolic reprogramming, signaling pathways, and mechanisms of drug resistance. She is a member of the European Association for Cancer Research, the Turkish Biochemical Society, and the Molecular Cancer Research Association (MOKAD).